Cytosorbents Corp Share Price OTC Bulletin Board
Equities
CTSO
US23283X1072
Advanced Medical Equipment & Technology
Sales 2024 * | 41.33M 3.45B | Sales 2025 * | 47.76M 3.99B | Capitalization | 45.16M 3.77B |
---|---|---|---|---|---|
Net income 2024 * | -20M -1.67B | Net income 2025 * | -9M -751M | EV / Sales 2024 * | 1.09 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.95 x |
P/E ratio 2024 * |
-2.31
x | P/E ratio 2025 * |
-4.09
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.8% |
Latest transcript on Cytosorbents Corp
Managers | Title | Age | Since |
---|---|---|---|
Phillip Chan
CEO | Chief Executive Officer | 53 | 24/08/24 |
Vincent Capponi
PSD | President | 66 | 25/02/25 |
Kathleen Bloch
DFI | Director of Finance/CFO | 69 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Bator
CHM | Chairman | 60 | 14/15/14 |
Phillip Chan
CEO | Chief Executive Officer | 53 | 24/08/24 |
Edward Jones
BRD | Director/Board Member | 75 | 01/07/01 |
1st Jan change | Capi. | |
---|---|---|
+12.06% | 227B | |
+12.07% | 192B | |
+13.88% | 136B | |
+27.12% | 108B | |
+0.38% | 64.07B | |
+13.39% | 52.1B | |
+6.74% | 51.87B | |
+8.81% | 44.33B | |
+4.14% | 36.75B |